[HTML][HTML] Considerations for diagnostic COVID-19 tests
O Vandenberg, D Martiny, O Rochas… - Nature Reviews …, 2021 - nature.com
During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design,
development, validation, verification and implementation of diagnostic tests were actively …
development, validation, verification and implementation of diagnostic tests were actively …
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic …
The COVID-19 pandemic is an unprecedented healthcare emergency causing mortality and
illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also …
illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also …
The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape
The world continues to face a life-threatening viral pandemic. The virus underlying the
Coronavirus Disease 2019 (COVID-19), Severe Acute Respiratory Syndrome Coronavirus 2 …
Coronavirus Disease 2019 (COVID-19), Severe Acute Respiratory Syndrome Coronavirus 2 …
Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19
Blood myeloid cells are known to be dysregulated in coronavirus disease 2019 (COVID-19),
caused by SARS-CoV-2. It is unknown whether the innate myeloid response differs with …
caused by SARS-CoV-2. It is unknown whether the innate myeloid response differs with …
An inflammatory cytokine signature predicts COVID-19 severity and survival
DM Del Valle, S Kim-Schulze, HH Huang… - Nature medicine, 2020 - nature.com
Several studies have revealed that the hyper-inflammatory response induced by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease …
Ischemic heart disease pathophysiology paradigms overview: from plaque activation to microvascular dysfunction
P Severino, A D'Amato, M Pucci, F Infusino… - International journal of …, 2020 - mdpi.com
Ischemic heart disease still represents a large burden on individuals and health care
resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow …
resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow …
Targeting the NLRP3 inflammasome in severe COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the genus
Betacoronavirus within the family Coronaviridae. It is an enveloped single-stranded positive …
Betacoronavirus within the family Coronaviridae. It is an enveloped single-stranded positive …
Novel systemic inflammation markers to predict COVID-19 prognosis
Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic, challenging both
the medical and scientific community for the development of novel vaccines and a greater …
the medical and scientific community for the development of novel vaccines and a greater …
Small molecules in the treatment of COVID-19
S Lei, X Chen, J Wu, X Duan, K Men - Signal transduction and targeted …, 2022 - nature.com
The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to
societies and economies. Until now, effective therapeutics against COVID-19 are in high …
societies and economies. Until now, effective therapeutics against COVID-19 are in high …
[HTML][HTML] Immunology of COVID-19: current state of the science
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …